Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Radiology
|
September 25, 2001
Assessment of myocardial infarction in humans with (23)Na MR imaging: comparison with cine MR imaging and delayed contrast enhancement
J J Sandstede, T Pabst, M Beer, et al.
Circulation
|
October 23, 1997
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy
S Neubauer, M Horn, M Cramer, et al.
Swiss Medical Weekly
|
May 12, 2010
Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations
C Taverna, M Bargetzi, D Betticher, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
August 28, 1999
[The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function]
M Beer, W Landschütz, M Meininger, et al.
Leukemia & Lymphoma
|
October 24, 2000
Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia
T Pabst, U R Peters, M Tinguely, et al.
Der Radiologe
|
April 12, 2000
[Cardiac energy metabolism in heart valve diseases with 31P MR spectroscopy]
M Beer, M Viehrig, T Seyfarth, et al.
European Radiology
|
August 12, 2000
Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans
M Beer, J Sandstede, W Landschütz, et al.
Bone Marrow Transplantation
|
October 24, 2017
NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma
B Jeker, U Novak, B Mansouri Taleghani, et al.
Magma (New York, N.Y.)
|
August 15, 2001
(31)P-MR Spectroscopy for the evaluation of energy metabolism in intact residual myocardium after acute myocardial infarction in humans
M Beer, S Buchner, J Sandstede, et al.
Blood Cancer Journal
|
August 29, 2019
Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
F Hitz, M Kraus, T Pabst, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Radiology
|
September 25, 2001
Assessment of myocardial infarction in humans with (23)Na MR imaging: comparison with cine MR imaging and delayed contrast enhancement
J J Sandstede, T Pabst, M Beer, et al.
Circulation
|
October 23, 1997
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy
S Neubauer, M Horn, M Cramer, et al.
Swiss Medical Weekly
|
May 12, 2010
Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations
C Taverna, M Bargetzi, D Betticher, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
August 28, 1999
[The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function]
M Beer, W Landschütz, M Meininger, et al.
Leukemia & Lymphoma
|
October 24, 2000
Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia
T Pabst, U R Peters, M Tinguely, et al.
Der Radiologe
|
April 12, 2000
[Cardiac energy metabolism in heart valve diseases with 31P MR spectroscopy]
M Beer, M Viehrig, T Seyfarth, et al.
European Radiology
|
August 12, 2000
Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans
M Beer, J Sandstede, W Landschütz, et al.
Bone Marrow Transplantation
|
October 24, 2017
NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma
B Jeker, U Novak, B Mansouri Taleghani, et al.
Magma (New York, N.Y.)
|
August 15, 2001
(31)P-MR Spectroscopy for the evaluation of energy metabolism in intact residual myocardium after acute myocardial infarction in humans
M Beer, S Buchner, J Sandstede, et al.
Blood Cancer Journal
|
August 29, 2019
Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
F Hitz, M Kraus, T Pabst, et al.
Page
of 9